PATRICK KEENAN: Open Payments
NPI 1649839861 · UTICA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,158 in 49 payments from 16 companies in 2025. Trend: 2023 $600 · 2024 $695 · 2025 $2,158
Food & beverage: $2,158
| Company | Payments | Amount |
|---|---|---|
| AOP Health US, LLC | 1 | $1,046 |
| Alnylam Pharmaceuticals Inc. | 6 | $220 |
| Novartis Pharmaceuticals Corporation | 10 | $201 |
| Amgen Inc. | 8 | $177 |
| PFIZER INC. | 7 | $137 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $108 |
| GlaxoSmithKline, LLC. | 1 | $88 |
| Novo Nordisk Inc | 2 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
Products named: Rapiblyk, LEQVIO, REPATHA, AMVUTTRA, ELIQUIS, JARDIANCE, ONPATTRO, PENMENVY.
Industry payments across NY — which companies pay providers there.
